false
0001868640
0001868640
2025-07-24
2025-07-24
0001868640
RDZN:OrdinarySharesParValue0.0001PerShareMember
2025-07-24
2025-07-24
0001868640
RDZN:WarrantsEachWarrantExercisableForOneOrdinaryShareEachAtExercisePriceOf11.50PerShareMember
2025-07-24
2025-07-24
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): July 24, 2025
ROADZEN
INC.
(Exact
name of Registrant as Specified in Its Charter)
British
Virgin Islands |
|
001-41094 |
|
98-1600102 |
(State
or Other Jurisdiction
of Incorporation) |
|
(Commission
File Number) |
|
(IRS
Employer
Identification No.) |
111
Anza Blvd
Suite
109 |
|
|
Burlingame,
California |
|
94010 |
(Address
of Principal Executive Offices) |
|
(Zip
Code) |
Registrant’s
Telephone Number, Including Area Code: (347)
745-6448
(Former
Name or Former Address, if Changed Since Last Report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
☐ | Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
☐ | Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
☐ | Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
☐ | Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange on which registered |
Ordinary
Shares, par value $0.0001 per share |
|
RDZN |
|
The
Nasdaq Stock Market LLC |
Warrants,
each warrant exercisable for one ordinary share, each at an exercise price of $11.50 per share |
|
RDZNW |
|
The
Nasdaq Stock Market LLC |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging
growth company ☒
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item
1.01 Entry into a Material Definitive Agreement.
On
July 24, 2025, Roadzen Inc. (the “Company”) entered into separate securities purchase agreements (the “Securities
Purchase Agreements”) with certain institutional investors (the “Investors”) pursuant to which the Company agreed to
issue and sell to the Investors, and the Investors agreed to purchase from the Company, an aggregate of 1,803,134 of the Company’s
ordinary shares, par value of $0.0001 per share (the “Ordinary Shares”), for a purchase price of $1.25 per share, or approximately
$2,253,917 in the aggregate. Avacara PTE Ltd. (“Avacara”), a significant shareholder of the Company, purchased 104,000 Ordinary
Shares for a purchase price of $130,000. The Company’s Chief Executive Officer and director, Rohan Malhotra, is the principal owner
and Managing Partner of Avacara.
Also
on July 24, 2025, the Company entered into a registration rights agreement with the Investors (the “Registration Rights Agreement”),
pursuant to which the Company agreed, among other things, to use its reasonable best efforts to file, on or before October 27, 2025,
a registration statement covering the resale of all of the Ordinary Shares sold pursuant to the Securities Purchase Agreements.
The
foregoing descriptions of the terms and conditions of the Securities Purchase Agreements and the Registration Rights Agreement do not
purport to be complete and are qualified in its entireties by the full text of the form of Securities Purchase Agreement and Registration
Rights Agreement, copies of which are filed as exhibits 10.1 and 10.2, respectively, to this Current Report on Form 8-K and incorporated
herein by reference.
Item
3.02 Unregistered Sales of Equity Securities.
The
information included in Item 1.01 of this Current Report is incorporated by reference into this Item 3.02 of this Current Report to the
extent required. The Ordinary Shares sold pursuant to the Securities Purchase Agreements have been offered and sold pursuant to exemptions
from the registration requirements of the Securities Act of 1933, as amended, afforded by Section 4(a)(2) thereof and Rule 506 of Regulation
D promulgated thereunder, for the sale of securities not involving a public offering.
Item
5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of
Certain Officers.
Also
on July 24, 2025, the Company entered into separate amendments (the “RSU Amendments”) to the restricted stock unit awards
(as previously amended, the “RSUs”) previously granted to Rohan Malhotra, the Company’s Chief Executive Officer and
a director, Jean-Noel Gallardo, the Company’s Chief Financial Officer, and Ankur Kamboj, the Company’s Chief Operating Officer.
Pursuant to the RSU Amendments, the 5,616,550 RSUs previously granted by the Company to Mr. Malhotra and the 1,250,007 RSUs previously
granted by the Company to Mr. Kamboj were each amended to change the date on which such RSUs vest in full (subject to the executive’s
continuous service with the Company through the vesting date) from September 17, 2025 to September 17, 2026, and the 115,000 RSUs previously
granted by the Company to Mr. Gallardo were amended to change the date on which such RSUs vest in full (subject to the executive’s
continuous service with the Company through the vesting date) from November 20, 2025 to November 20, 2026.
The
foregoing description of the RSU Amendments does not purport to be complete and is qualified in its entirety by reference to the full
text of the RSU Amendments, the form of which is filed as Exhibit 10.3 to this Current Report on Form 8-K and incorporated herein by
reference.
Item
9.01 Financial Statements and Exhibits.
(d)
Exhibits.
Exhibit
Number |
|
Description
of Exhibit |
|
|
|
10.1 |
|
Form of Securities Purchase Agreement. |
10.2 |
|
Form of Registration Rights Agreement. |
10.3 |
|
Form of Amendment to Restricted Stock Unit Award Grant Notice and Restricted Stock Unit Award Agreement. |
104 |
|
Cover
page interactive data file (embedded within the Inline XBRL document). |
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
|
|
ROADZEN INC. |
|
|
|
|
Date: |
July
30, 2025 |
By: |
/s/
Jean-Noel Gallardo |
|
|
Name: |
Jean-Noel
Gallardo |
|
|
Title: |
Chief
Financial Officer |